

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.39818656 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.39818656 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.29381981 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.23573645 |
| 5 | protein neddylation (GO:0045116) | 5.09200974 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 4.90177032 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.90177032 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 4.54935951 |
| 9 | proteasome assembly (GO:0043248) | 4.49625108 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.38894237 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 4.38894237 |
| 12 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.38894237 |
| 13 | cullin deneddylation (GO:0010388) | 4.29955370 |
| 14 | respiratory electron transport chain (GO:0022904) | 4.28367793 |
| 15 | protein complex biogenesis (GO:0070271) | 4.22115799 |
| 16 | termination of RNA polymerase III transcription (GO:0006386) | 4.21179286 |
| 17 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.21179286 |
| 18 | electron transport chain (GO:0022900) | 4.19158283 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.13635840 |
| 20 | protein deneddylation (GO:0000338) | 3.91869443 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.85841656 |
| 22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.85701855 |
| 23 | pseudouridine synthesis (GO:0001522) | 3.77381519 |
| 24 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.73944638 |
| 25 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.73944638 |
| 26 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.72249935 |
| 27 | GTP biosynthetic process (GO:0006183) | 3.68141729 |
| 28 | ribosomal small subunit biogenesis (GO:0042274) | 3.62112350 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 3.62024138 |
| 30 | 7-methylguanosine mRNA capping (GO:0006370) | 3.57946901 |
| 31 | negative regulation of ligase activity (GO:0051352) | 3.53990401 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.53990401 |
| 33 | 7-methylguanosine RNA capping (GO:0009452) | 3.53380201 |
| 34 | RNA capping (GO:0036260) | 3.53380201 |
| 35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.49630356 |
| 36 | fatty acid elongation (GO:0030497) | 3.47314074 |
| 37 | translational elongation (GO:0006414) | 3.46949649 |
| 38 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.46833590 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.45896684 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.40043092 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34606652 |
| 42 | protein targeting to mitochondrion (GO:0006626) | 3.33698943 |
| 43 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.33473695 |
| 44 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.32880136 |
| 45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.30937532 |
| 46 | platelet dense granule organization (GO:0060155) | 3.30749530 |
| 47 | ATP biosynthetic process (GO:0006754) | 3.30742305 |
| 48 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.27476849 |
| 49 | respiratory chain complex IV assembly (GO:0008535) | 3.23363043 |
| 50 | base-excision repair, AP site formation (GO:0006285) | 3.21897185 |
| 51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.21754251 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.21754251 |
| 53 | inner mitochondrial membrane organization (GO:0007007) | 3.21351541 |
| 54 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.21107695 |
| 55 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.21107695 |
| 56 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.21107695 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.18403420 |
| 58 | termination of RNA polymerase I transcription (GO:0006363) | 3.18301917 |
| 59 | establishment of protein localization to mitochondrion (GO:0072655) | 3.15595948 |
| 60 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.14469669 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.13417697 |
| 62 | proton transport (GO:0015992) | 3.13341648 |
| 63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.13152974 |
| 64 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.12743845 |
| 65 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11455021 |
| 66 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11455021 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.10340372 |
| 68 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.09273627 |
| 69 | protein-cofactor linkage (GO:0018065) | 3.09241588 |
| 70 | viral life cycle (GO:0019058) | 3.08797787 |
| 71 | translational initiation (GO:0006413) | 3.07781435 |
| 72 | peptidyl-histidine modification (GO:0018202) | 3.06905547 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06892640 |
| 74 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.05757890 |
| 75 | hydrogen transport (GO:0006818) | 3.04921554 |
| 76 | UTP biosynthetic process (GO:0006228) | 3.01891009 |
| 77 | rRNA methylation (GO:0031167) | 3.01255327 |
| 78 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.00336483 |
| 79 | DNA damage response, detection of DNA damage (GO:0042769) | 2.99651193 |
| 80 | transcription from RNA polymerase I promoter (GO:0006360) | 2.96804418 |
| 81 | L-methionine salvage (GO:0071267) | 2.96248354 |
| 82 | L-methionine biosynthetic process (GO:0071265) | 2.96248354 |
| 83 | amino acid salvage (GO:0043102) | 2.96248354 |
| 84 | tRNA processing (GO:0008033) | 2.95745775 |
| 85 | mannosylation (GO:0097502) | 2.95315514 |
| 86 | rRNA processing (GO:0006364) | 2.94921842 |
| 87 | viral transcription (GO:0019083) | 2.94499865 |
| 88 | deoxyribonucleotide catabolic process (GO:0009264) | 2.92514806 |
| 89 | presynaptic membrane organization (GO:0097090) | 2.91942841 |
| 90 | maturation of 5.8S rRNA (GO:0000460) | 2.91667837 |
| 91 | protein localization to cilium (GO:0061512) | 2.91232055 |
| 92 | rRNA modification (GO:0000154) | 2.90608166 |
| 93 | cellular protein complex disassembly (GO:0043624) | 2.90049849 |
| 94 | protein localization to mitochondrion (GO:0070585) | 2.89676676 |
| 95 | rRNA metabolic process (GO:0016072) | 2.89509159 |
| 96 | mitochondrial transport (GO:0006839) | 2.89325801 |
| 97 | cotranslational protein targeting to membrane (GO:0006613) | 2.89108556 |
| 98 | translational termination (GO:0006415) | 2.88976950 |
| 99 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.88744769 |
| 100 | cytochrome complex assembly (GO:0017004) | 2.87883224 |
| 101 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.86211579 |
| 102 | protein K6-linked ubiquitination (GO:0085020) | 2.84380676 |
| 103 | positive regulation of protein homodimerization activity (GO:0090073) | 2.83861855 |
| 104 | positive regulation of ligase activity (GO:0051351) | 2.82342443 |
| 105 | regulation of mitochondrial translation (GO:0070129) | 2.81720624 |
| 106 | translation (GO:0006412) | 2.81287793 |
| 107 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81239116 |
| 108 | GPI anchor biosynthetic process (GO:0006506) | 2.81230560 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.81174741 |
| 110 | deoxyribose phosphate catabolic process (GO:0046386) | 2.80639592 |
| 111 | DNA deamination (GO:0045006) | 2.80192681 |
| 112 | viral mRNA export from host cell nucleus (GO:0046784) | 2.79790881 |
| 113 | spliceosomal snRNP assembly (GO:0000387) | 2.79058113 |
| 114 | protein targeting to ER (GO:0045047) | 2.79002639 |
| 115 | ribosomal large subunit biogenesis (GO:0042273) | 2.78875939 |
| 116 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.78492430 |
| 117 | DNA double-strand break processing (GO:0000729) | 2.77954680 |
| 118 | microtubule polymerization or depolymerization (GO:0031109) | 2.77710585 |
| 119 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.77607347 |
| 120 | cellular component biogenesis (GO:0044085) | 2.75318079 |
| 121 | maturation of SSU-rRNA (GO:0030490) | 2.74027124 |
| 122 | substantia nigra development (GO:0021762) | 2.73973842 |
| 123 | spliceosomal complex assembly (GO:0000245) | 2.73886164 |
| 124 | neurotransmitter uptake (GO:0001504) | 2.73579235 |
| 125 | neuron cell-cell adhesion (GO:0007158) | 2.73385845 |
| 126 | intracellular protein transmembrane import (GO:0044743) | 2.72759716 |
| 127 | hydrogen ion transmembrane transport (GO:1902600) | 2.71139809 |
| 128 | protein localization to endoplasmic reticulum (GO:0070972) | 2.71084718 |
| 129 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.69059181 |
| 130 | regulation of cellular amine metabolic process (GO:0033238) | 2.68453222 |
| 131 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.67474097 |
| 132 | regulation of collateral sprouting (GO:0048670) | 2.66272368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.81667487 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.68187660 |
| 3 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.34970120 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.22117906 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.18463041 |
| 6 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.04013506 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.84464748 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.68639724 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.38784733 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.38298436 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.30538640 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.29231292 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.04245986 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.96417276 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.63315029 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61639785 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.60832628 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.54314513 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.49805113 |
| 20 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.31288180 |
| 21 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.20545304 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.18506509 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.17669482 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.06104338 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91202996 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.89802055 |
| 27 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85388660 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84510085 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78305277 |
| 30 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.76175660 |
| 31 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71231086 |
| 32 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.68771616 |
| 33 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67275476 |
| 34 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63154512 |
| 35 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62809836 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58547829 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.54520421 |
| 38 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53080258 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.52970406 |
| 40 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.49768646 |
| 41 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.49289279 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48132281 |
| 43 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44744224 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.42912000 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41240732 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41181371 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38733358 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38169159 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36232290 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33855146 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29787906 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.28605523 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26645800 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.26189004 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26128552 |
| 56 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.25914813 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25505260 |
| 58 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.25049477 |
| 59 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22007926 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.20568900 |
| 61 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18342364 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15912451 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14313483 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13683402 |
| 65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.10298870 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09889786 |
| 67 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.09368810 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09095407 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08095242 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06855731 |
| 71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03181489 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02737059 |
| 73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02087538 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01357652 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00681537 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99718712 |
| 77 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98917413 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98510081 |
| 79 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96438882 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.95754715 |
| 81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95685111 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95465648 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94338512 |
| 84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93482978 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91227943 |
| 86 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91227943 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90538746 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90468432 |
| 89 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.90075660 |
| 90 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89104105 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88990461 |
| 92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88497406 |
| 93 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88398630 |
| 94 | EWS_26573619_Chip-Seq_HEK293_Human | 0.88392380 |
| 95 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.88144272 |
| 96 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.88114855 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87417776 |
| 98 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87209037 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86912019 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86163835 |
| 101 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.85199915 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84505213 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.84083668 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.83684480 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83230944 |
| 106 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83104008 |
| 107 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.82391010 |
| 108 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81022121 |
| 109 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80285599 |
| 110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79914924 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79672062 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.79286365 |
| 113 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78830962 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78798289 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.78443311 |
| 116 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78280568 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77794387 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76999310 |
| 119 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.76542860 |
| 120 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.76452884 |
| 121 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74278717 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73340176 |
| 123 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.72411195 |
| 124 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.71610567 |
| 125 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.71439597 |
| 126 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.69534553 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67989462 |
| 128 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.67825441 |
| 129 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67646268 |
| 130 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.67456430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.71659020 |
| 2 | MP0003880_abnormal_central_pattern | 3.42122764 |
| 3 | MP0001529_abnormal_vocalization | 3.31436804 |
| 4 | MP0001905_abnormal_dopamine_level | 2.98099793 |
| 5 | MP0001986_abnormal_taste_sensitivity | 2.89976685 |
| 6 | MP0001188_hyperpigmentation | 2.65000275 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.63102236 |
| 8 | MP0003136_yellow_coat_color | 2.61833766 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.56061542 |
| 10 | MP0003186_abnormal_redox_activity | 2.40369865 |
| 11 | MP0005171_absent_coat_pigmentation | 2.35544872 |
| 12 | MP0000920_abnormal_myelination | 2.18953908 |
| 13 | MP0008057_abnormal_DNA_replication | 2.11815980 |
| 14 | MP0005084_abnormal_gallbladder_morpholo | 2.08480678 |
| 15 | MP0004142_abnormal_muscle_tone | 2.00800392 |
| 16 | MP0009379_abnormal_foot_pigmentation | 1.83498018 |
| 17 | MP0008260_abnormal_autophagy | 1.68938962 |
| 18 | MP0002272_abnormal_nervous_system | 1.68590942 |
| 19 | MP0008872_abnormal_physiological_respon | 1.63167760 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.62451288 |
| 21 | MP0008932_abnormal_embryonic_tissue | 1.58635219 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 1.54636136 |
| 23 | MP0004381_abnormal_hair_follicle | 1.53998609 |
| 24 | MP0008058_abnormal_DNA_repair | 1.51235384 |
| 25 | MP0002938_white_spotting | 1.50893021 |
| 26 | MP0002102_abnormal_ear_morphology | 1.49072772 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.47955003 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.47035478 |
| 29 | MP0001486_abnormal_startle_reflex | 1.47027034 |
| 30 | MP0003718_maternal_effect | 1.46974815 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.45014122 |
| 32 | MP0001764_abnormal_homeostasis | 1.43226154 |
| 33 | MP0002064_seizures | 1.39526068 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.39129738 |
| 35 | MP0005671_abnormal_response_to | 1.39016884 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.38487209 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.34645130 |
| 38 | MP0002163_abnormal_gland_morphology | 1.33255027 |
| 39 | MP0001984_abnormal_olfaction | 1.32715323 |
| 40 | MP0005389_reproductive_system_phenotype | 1.32178267 |
| 41 | MP0004742_abnormal_vestibular_system | 1.32081091 |
| 42 | MP0009046_muscle_twitch | 1.31969690 |
| 43 | MP0005409_darkened_coat_color | 1.31964187 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.31576888 |
| 45 | MP0009764_decreased_sensitivity_to | 1.30674536 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.30004555 |
| 47 | MP0004957_abnormal_blastocyst_morpholog | 1.29045332 |
| 48 | MP0001919_abnormal_reproductive_system | 1.27630998 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.25109003 |
| 50 | MP0003646_muscle_fatigue | 1.24426152 |
| 51 | MP0008995_early_reproductive_senescence | 1.23895367 |
| 52 | MP0009745_abnormal_behavioral_response | 1.22691715 |
| 53 | MP0001800_abnormal_humoral_immune | 1.22517178 |
| 54 | MP0002736_abnormal_nociception_after | 1.22485219 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.22337729 |
| 56 | MP0010094_abnormal_chromosome_stability | 1.19048124 |
| 57 | MP0002734_abnormal_mechanical_nocicepti | 1.18603334 |
| 58 | MP0004147_increased_porphyrin_level | 1.18402355 |
| 59 | MP0004270_analgesia | 1.16303467 |
| 60 | MP0003195_calcinosis | 1.16235209 |
| 61 | MP0005410_abnormal_fertilization | 1.15978780 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 1.15877028 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.15614972 |
| 64 | MP0001542_abnormal_bone_strength | 1.15404145 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.15121034 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.14923981 |
| 67 | MP0003786_premature_aging | 1.14177612 |
| 68 | MP0005310_abnormal_salivary_gland | 1.13776261 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.13440697 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.12904831 |
| 71 | MP0000778_abnormal_nervous_system | 1.07598854 |
| 72 | MP0005000_abnormal_immune_tolerance | 1.07351980 |
| 73 | MP0002723_abnormal_immune_serum | 1.07178895 |
| 74 | MP0009697_abnormal_copulation | 1.06316662 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.03902013 |
| 76 | MP0002009_preneoplasia | 1.03226333 |
| 77 | MP0002067_abnormal_sensory_capabilities | 1.03043100 |
| 78 | MP0003950_abnormal_plasma_membrane | 1.03040027 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.01372759 |
| 80 | MP0000685_abnormal_immune_system | 1.00382206 |
| 81 | MP0002229_neurodegeneration | 1.00058133 |
| 82 | MP0003077_abnormal_cell_cycle | 0.99730069 |
| 83 | MP0002132_abnormal_respiratory_system | 0.99111025 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.98591821 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.97832576 |
| 86 | MP0009785_altered_susceptibility_to | 0.96483347 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.95991606 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.95567449 |
| 89 | MP0002420_abnormal_adaptive_immunity | 0.95115166 |
| 90 | MP0001819_abnormal_immune_cell | 0.94246950 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.93818961 |
| 92 | MP0003878_abnormal_ear_physiology | 0.93209419 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.93209419 |
| 94 | MP0002210_abnormal_sex_determination | 0.93156569 |
| 95 | MP0004134_abnormal_chest_morphology | 0.90889795 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.89319988 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.88051020 |
| 98 | MP0005025_abnormal_response_to | 0.88045756 |
| 99 | MP0000358_abnormal_cell_content/ | 0.88005272 |
| 100 | MP0001929_abnormal_gametogenesis | 0.87910878 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.86958622 |
| 102 | MP0002751_abnormal_autonomic_nervous | 0.86410885 |
| 103 | MP0003938_abnormal_ear_development | 0.86383097 |
| 104 | MP0004133_heterotaxia | 0.85735818 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.85323295 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.84455208 |
| 107 | MP0001790_abnormal_immune_system | 0.84156548 |
| 108 | MP0005387_immune_system_phenotype | 0.84156548 |
| 109 | MP0002160_abnormal_reproductive_system | 0.83460728 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.83255750 |
| 111 | MP0001970_abnormal_pain_threshold | 0.83209166 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.83139273 |
| 113 | MP0003634_abnormal_glial_cell | 0.82964219 |
| 114 | MP0003724_increased_susceptibility_to | 0.82788848 |
| 115 | MP0005253_abnormal_eye_physiology | 0.81883132 |
| 116 | MP0001853_heart_inflammation | 0.81437417 |
| 117 | MP0003787_abnormal_imprinting | 0.80818012 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.80564930 |
| 119 | MP0000026_abnormal_inner_ear | 0.79008514 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.78818638 |
| 121 | MP0001293_anophthalmia | 0.78288772 |
| 122 | MP0003011_delayed_dark_adaptation | 0.77133600 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.76930058 |
| 124 | MP0003763_abnormal_thymus_physiology | 0.76802613 |
| 125 | MP0000566_synostosis | 0.76734310 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.76183405 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.76131435 |
| 128 | MP0002396_abnormal_hematopoietic_system | 0.75520199 |
| 129 | MP0000689_abnormal_spleen_morphology | 0.74956328 |
| 130 | MP0005332_abnormal_amino_acid | 0.74469476 |
| 131 | MP0003635_abnormal_synaptic_transmissio | 0.74449988 |
| 132 | MP0005394_taste/olfaction_phenotype | 0.74059950 |
| 133 | MP0005499_abnormal_olfactory_system | 0.74059950 |
| 134 | MP0003111_abnormal_nucleus_morphology | 0.73922827 |
| 135 | MP0000716_abnormal_immune_system | 0.73794622 |
| 136 | MP0001835_abnormal_antigen_presentation | 0.73516517 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.73000617 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.72125454 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.70819514 |
| 140 | MP0000653_abnormal_sex_gland | 0.70058609 |
| 141 | MP0003436_decreased_susceptibility_to | 0.70057083 |
| 142 | MP0008873_increased_physiological_sensi | 0.70009657 |
| 143 | MP0001145_abnormal_male_reproductive | 0.69877605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.19034742 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.72382755 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.48110280 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.43903984 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.20881161 |
| 6 | Cerebral hypomyelination (HP:0006808) | 4.07849835 |
| 7 | Increased CSF lactate (HP:0002490) | 4.04185099 |
| 8 | Acute encephalopathy (HP:0006846) | 3.94588758 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.84331873 |
| 10 | Hepatic necrosis (HP:0002605) | 3.48769404 |
| 11 | Leukodystrophy (HP:0002415) | 3.43260851 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.40534519 |
| 13 | Increased serum pyruvate (HP:0003542) | 3.27806570 |
| 14 | Abnormality of glycolysis (HP:0004366) | 3.27806570 |
| 15 | Medial flaring of the eyebrow (HP:0010747) | 3.19871303 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.17066501 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.16996403 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.16017807 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.15928143 |
| 20 | Aplastic anemia (HP:0001915) | 3.02240442 |
| 21 | Parakeratosis (HP:0001036) | 3.01586861 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.98291783 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.98291783 |
| 24 | CNS hypomyelination (HP:0003429) | 2.93394346 |
| 25 | Lipid accumulation in hepatocytes (HP:0006561) | 2.83594069 |
| 26 | Abnormal hair whorl (HP:0010721) | 2.83142210 |
| 27 | Optic disc pallor (HP:0000543) | 2.82699620 |
| 28 | Increased serum lactate (HP:0002151) | 2.82622968 |
| 29 | Increased muscle lipid content (HP:0009058) | 2.81339170 |
| 30 | Respiratory failure (HP:0002878) | 2.72895099 |
| 31 | Exercise intolerance (HP:0003546) | 2.71370140 |
| 32 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.70057626 |
| 33 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.70057626 |
| 34 | Congenital primary aphakia (HP:0007707) | 2.62931410 |
| 35 | Abnormal ciliary motility (HP:0012262) | 2.62276089 |
| 36 | Gait imbalance (HP:0002141) | 2.61992452 |
| 37 | Nephrogenic diabetes insipidus (HP:0009806) | 2.57536643 |
| 38 | Stomatitis (HP:0010280) | 2.50403140 |
| 39 | Lactic acidosis (HP:0003128) | 2.49223283 |
| 40 | Microvesicular hepatic steatosis (HP:0001414) | 2.49093625 |
| 41 | Hypothermia (HP:0002045) | 2.46416630 |
| 42 | Methylmalonic aciduria (HP:0012120) | 2.44147353 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.42750853 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.42750853 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.41246733 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.40337630 |
| 47 | Lethargy (HP:0001254) | 2.37575126 |
| 48 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.35648697 |
| 49 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31050737 |
| 50 | Pendular nystagmus (HP:0012043) | 2.28715681 |
| 51 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.28181676 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.25127435 |
| 53 | Exertional dyspnea (HP:0002875) | 2.24488499 |
| 54 | Pancytopenia (HP:0001876) | 2.23311642 |
| 55 | Cerebral edema (HP:0002181) | 2.22611202 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.21704965 |
| 57 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.19637791 |
| 58 | Vaginal atresia (HP:0000148) | 2.19029237 |
| 59 | Patchy hypopigmentation of hair (HP:0011365) | 2.17725749 |
| 60 | Abnormality of alanine metabolism (HP:0010916) | 2.17699908 |
| 61 | Hyperalaninemia (HP:0003348) | 2.17699908 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.17699908 |
| 63 | Breast hypoplasia (HP:0003187) | 2.17025010 |
| 64 | Genital tract atresia (HP:0001827) | 2.16039516 |
| 65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14721112 |
| 66 | Abnormal number of erythroid precursors (HP:0012131) | 2.13163832 |
| 67 | Birth length less than 3rd percentile (HP:0003561) | 2.12672262 |
| 68 | Nephronophthisis (HP:0000090) | 2.12522265 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.12050678 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10838419 |
| 71 | Sensory axonal neuropathy (HP:0003390) | 2.09919308 |
| 72 | Macrocytic anemia (HP:0001972) | 2.09560240 |
| 73 | Reticulocytopenia (HP:0001896) | 2.08770960 |
| 74 | Pancreatic cysts (HP:0001737) | 2.05365766 |
| 75 | CNS demyelination (HP:0007305) | 2.03908215 |
| 76 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02467678 |
| 77 | Absent/shortened dynein arms (HP:0200106) | 2.02467678 |
| 78 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.02348452 |
| 79 | Absent thumb (HP:0009777) | 2.02040784 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.00272054 |
| 81 | Abnormality of renal resorption (HP:0011038) | 1.99075662 |
| 82 | White forelock (HP:0002211) | 1.98188779 |
| 83 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.97678759 |
| 84 | Respiratory difficulties (HP:0002880) | 1.97342078 |
| 85 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.96890583 |
| 86 | Progressive microcephaly (HP:0000253) | 1.96753130 |
| 87 | Rough bone trabeculation (HP:0100670) | 1.95763154 |
| 88 | Peripheral hypomyelination (HP:0007182) | 1.95583304 |
| 89 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.94846897 |
| 90 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.94703025 |
| 91 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94208274 |
| 92 | Abnormal protein glycosylation (HP:0012346) | 1.93102944 |
| 93 | Abnormal glycosylation (HP:0012345) | 1.93102944 |
| 94 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.93102944 |
| 95 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.93102944 |
| 96 | Glycosuria (HP:0003076) | 1.92965111 |
| 97 | Abnormality of urine glucose concentration (HP:0011016) | 1.92965111 |
| 98 | Poor coordination (HP:0002370) | 1.92551309 |
| 99 | Sclerocornea (HP:0000647) | 1.92543356 |
| 100 | Asplenia (HP:0001746) | 1.91713401 |
| 101 | Rhinitis (HP:0012384) | 1.89522055 |
| 102 | Spastic paraparesis (HP:0002313) | 1.87414010 |
| 103 | True hermaphroditism (HP:0010459) | 1.86957591 |
| 104 | Abnormal pupillary function (HP:0007686) | 1.85887159 |
| 105 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85395218 |
| 106 | Hypoplastic pelvis (HP:0008839) | 1.85271698 |
| 107 | Oral leukoplakia (HP:0002745) | 1.83625975 |
| 108 | Constricted visual fields (HP:0001133) | 1.83060493 |
| 109 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.81281377 |
| 110 | Meckel diverticulum (HP:0002245) | 1.81073180 |
| 111 | IgG deficiency (HP:0004315) | 1.80669268 |
| 112 | Abnormality of the ileum (HP:0001549) | 1.80013059 |
| 113 | Focal motor seizures (HP:0011153) | 1.79736648 |
| 114 | Adrenal hypoplasia (HP:0000835) | 1.77226011 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76045582 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 1.76045582 |
| 117 | Esotropia (HP:0000565) | 1.75622686 |
| 118 | Muscle fiber atrophy (HP:0100295) | 1.75419791 |
| 119 | Hypoplasia of the uterus (HP:0000013) | 1.75006699 |
| 120 | Colon cancer (HP:0003003) | 1.74318452 |
| 121 | Cleft eyelid (HP:0000625) | 1.74189115 |
| 122 | Emotional lability (HP:0000712) | 1.74025497 |
| 123 | Abnormality of serum amino acid levels (HP:0003112) | 1.73976900 |
| 124 | Neutropenia (HP:0001875) | 1.72852724 |
| 125 | Abnormality of the renal medulla (HP:0100957) | 1.71564017 |
| 126 | Delusions (HP:0000746) | 1.69684675 |
| 127 | X-linked dominant inheritance (HP:0001423) | 1.69457075 |
| 128 | Blindness (HP:0000618) | 1.67216485 |
| 129 | Progressive external ophthalmoplegia (HP:0000590) | 1.66145511 |
| 130 | Abnormality of the septum pellucidum (HP:0007375) | 1.66009217 |
| 131 | Microretrognathia (HP:0000308) | 1.65727181 |
| 132 | Septo-optic dysplasia (HP:0100842) | 1.64379136 |
| 133 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.64164663 |
| 134 | Hyperglycinemia (HP:0002154) | 1.63678129 |
| 135 | Abnormality of midbrain morphology (HP:0002418) | 1.63460613 |
| 136 | Molar tooth sign on MRI (HP:0002419) | 1.63460613 |
| 137 | Anencephaly (HP:0002323) | 1.61602545 |
| 138 | Attenuation of retinal blood vessels (HP:0007843) | 1.61419353 |
| 139 | Abnormality of the preputium (HP:0100587) | 1.58536925 |
| 140 | Type II lissencephaly (HP:0007260) | 1.58422840 |
| 141 | Hepatosplenomegaly (HP:0001433) | 1.58354092 |
| 142 | Irregular epiphyses (HP:0010582) | 1.58145829 |
| 143 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.57681949 |
| 144 | Absent epiphyses (HP:0010577) | 1.57681949 |
| 145 | Cystic liver disease (HP:0006706) | 1.57234893 |
| 146 | Poor speech (HP:0002465) | 1.57121788 |
| 147 | Type 2 muscle fiber atrophy (HP:0003554) | 1.57075750 |
| 148 | External ophthalmoplegia (HP:0000544) | 1.56589233 |
| 149 | Pallor (HP:0000980) | 1.55398024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.96467652 |
| 2 | BUB1 | 3.20701671 |
| 3 | CASK | 3.02067339 |
| 4 | STK16 | 2.77923310 |
| 5 | STK39 | 2.76750910 |
| 6 | SRPK1 | 2.59672579 |
| 7 | BCKDK | 2.54867911 |
| 8 | MST4 | 2.31392189 |
| 9 | NUAK1 | 2.27990873 |
| 10 | EIF2AK1 | 2.20449935 |
| 11 | TSSK6 | 2.18652185 |
| 12 | OXSR1 | 2.17148047 |
| 13 | TNIK | 2.13988286 |
| 14 | MAP3K12 | 1.97511733 |
| 15 | VRK1 | 1.93508738 |
| 16 | TLK1 | 1.85829633 |
| 17 | TAOK3 | 1.84456085 |
| 18 | CDC7 | 1.78244965 |
| 19 | TESK2 | 1.74026876 |
| 20 | MAP4K2 | 1.70077357 |
| 21 | BCR | 1.67524634 |
| 22 | WEE1 | 1.66514140 |
| 23 | WNK3 | 1.64499537 |
| 24 | NME1 | 1.63409666 |
| 25 | MAPKAPK5 | 1.62494604 |
| 26 | PLK4 | 1.60476633 |
| 27 | CDK19 | 1.59907935 |
| 28 | PNCK | 1.59673707 |
| 29 | INSRR | 1.58474353 |
| 30 | FRK | 1.52503821 |
| 31 | TRIM28 | 1.50279511 |
| 32 | IRAK4 | 1.49914198 |
| 33 | LIMK1 | 1.47675151 |
| 34 | ADRBK2 | 1.46176435 |
| 35 | AKT3 | 1.43523464 |
| 36 | GRK7 | 1.41074168 |
| 37 | MKNK1 | 1.34988994 |
| 38 | MAP2K7 | 1.31331640 |
| 39 | PKN1 | 1.28066563 |
| 40 | PBK | 1.27584745 |
| 41 | MUSK | 1.26728522 |
| 42 | ACVR1B | 1.19602479 |
| 43 | CSNK1G3 | 1.18897684 |
| 44 | BRSK2 | 1.18777475 |
| 45 | NEK6 | 1.16702220 |
| 46 | PDK2 | 1.14567362 |
| 47 | MYLK | 1.14440589 |
| 48 | TXK | 1.13703636 |
| 49 | CCNB1 | 1.13099485 |
| 50 | MKNK2 | 1.11446106 |
| 51 | IRAK2 | 1.11174309 |
| 52 | DYRK2 | 1.10817352 |
| 53 | NME2 | 1.10057523 |
| 54 | MAPK13 | 1.09852783 |
| 55 | EIF2AK3 | 1.09680743 |
| 56 | SIK3 | 1.06433799 |
| 57 | MAPKAPK3 | 1.05118730 |
| 58 | IRAK3 | 1.04213890 |
| 59 | ABL2 | 1.03835130 |
| 60 | CLK1 | 1.03122005 |
| 61 | BMPR2 | 1.00652644 |
| 62 | PIM2 | 1.00458228 |
| 63 | BRAF | 0.99069197 |
| 64 | BMPR1B | 0.92984782 |
| 65 | KDR | 0.91307420 |
| 66 | CDK8 | 0.86949002 |
| 67 | ARAF | 0.85235872 |
| 68 | EIF2AK2 | 0.83344385 |
| 69 | CSNK1G1 | 0.81996827 |
| 70 | TGFBR1 | 0.81616186 |
| 71 | ZAK | 0.79199475 |
| 72 | MAPK15 | 0.78620092 |
| 73 | CAMK2B | 0.77778348 |
| 74 | NEK1 | 0.75827641 |
| 75 | GRK1 | 0.73371966 |
| 76 | IRAK1 | 0.73309830 |
| 77 | UHMK1 | 0.72938260 |
| 78 | CSNK1A1L | 0.72543613 |
| 79 | RPS6KA5 | 0.72263626 |
| 80 | TAF1 | 0.72192958 |
| 81 | WNK4 | 0.71072888 |
| 82 | PIK3CG | 0.70236868 |
| 83 | ATR | 0.69143383 |
| 84 | PLK2 | 0.68990826 |
| 85 | PLK3 | 0.68718483 |
| 86 | GRK6 | 0.67680039 |
| 87 | YES1 | 0.62555597 |
| 88 | SYK | 0.61308634 |
| 89 | MAP3K11 | 0.60761356 |
| 90 | CSNK1G2 | 0.60432682 |
| 91 | OBSCN | 0.60346995 |
| 92 | PRPF4B | 0.59402604 |
| 93 | AURKB | 0.58479654 |
| 94 | GRK5 | 0.57979558 |
| 95 | PINK1 | 0.57503241 |
| 96 | DAPK1 | 0.57239162 |
| 97 | CDK3 | 0.56979320 |
| 98 | SGK223 | 0.55946904 |
| 99 | SGK494 | 0.55946904 |
| 100 | MARK3 | 0.54285755 |
| 101 | KIT | 0.53502021 |
| 102 | TESK1 | 0.53186042 |
| 103 | ROCK2 | 0.52820849 |
| 104 | AURKA | 0.51053256 |
| 105 | MAP3K14 | 0.49200855 |
| 106 | DYRK3 | 0.49184667 |
| 107 | PRKCG | 0.49128091 |
| 108 | CAMKK2 | 0.48970365 |
| 109 | PHKG2 | 0.48721406 |
| 110 | PHKG1 | 0.48721406 |
| 111 | STK24 | 0.48625611 |
| 112 | MAP3K6 | 0.47864435 |
| 113 | TNK2 | 0.47729427 |
| 114 | PRKCQ | 0.47567938 |
| 115 | TRPM7 | 0.47440006 |
| 116 | CSNK2A1 | 0.47410769 |
| 117 | NLK | 0.46949434 |
| 118 | ILK | 0.46147278 |
| 119 | BRSK1 | 0.45595510 |
| 120 | CSNK2A2 | 0.44315702 |
| 121 | ADRBK1 | 0.44084238 |
| 122 | IKBKE | 0.42731726 |
| 123 | PLK1 | 0.42370186 |
| 124 | CAMK2G | 0.41808977 |
| 125 | MAP4K1 | 0.40231967 |
| 126 | CAMK2D | 0.39707531 |
| 127 | TEC | 0.39456030 |
| 128 | PIM1 | 0.38604575 |
| 129 | CSNK1A1 | 0.38588920 |
| 130 | ITK | 0.38372366 |
| 131 | CAMK2A | 0.37831034 |
| 132 | DAPK3 | 0.37452659 |
| 133 | FES | 0.37427848 |
| 134 | CHUK | 0.36656929 |
| 135 | LRRK2 | 0.35229278 |
| 136 | PRKCI | 0.35188950 |
| 137 | LYN | 0.35138721 |
| 138 | PRKCE | 0.35026799 |
| 139 | MAP3K4 | 0.34926306 |
| 140 | IKBKB | 0.34461022 |
| 141 | PAK1 | 0.32368261 |
| 142 | CHEK2 | 0.32226869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.67848260 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.34617476 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.88643462 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.85293481 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.77444594 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.10481358 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.83788813 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.80681322 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.45671488 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.30909808 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 1.98980633 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.98554739 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.92668091 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.85862356 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85111743 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 1.82526877 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.79157965 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.75954007 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.74008970 |
| 20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72931763 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68619527 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.57535272 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51011233 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49058693 |
| 25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42288782 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.38188801 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31567578 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31378882 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26175956 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.24208381 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.17909965 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.16114523 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.14262363 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10325627 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10067733 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.09304718 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08304107 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05118984 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04381349 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03520700 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01504366 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99988424 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 0.97285912 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96711910 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91126406 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89383246 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87789031 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83265854 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81884872 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 0.80962746 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79133480 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77824837 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.77461857 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75077400 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74591395 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73915517 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71496675 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70658952 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67742837 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67509902 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67323836 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67098157 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.65226789 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63791968 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63403525 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62979021 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61624813 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61186987 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56305834 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53579998 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52998581 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51900323 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51162089 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49838191 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.49677161 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47923016 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47574858 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45881184 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45221802 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43572119 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42994341 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41028148 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40920755 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40437105 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39843679 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39794248 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38304809 |
| 88 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35836755 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31304555 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30746481 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30605511 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29776877 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29564580 |
| 94 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29322704 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28077266 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.28007924 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27954474 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27675710 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.27310355 |
| 100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26607093 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.25711542 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25442299 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24419149 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24383599 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24166181 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23822399 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23220291 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23025505 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22939113 |
| 110 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.22761698 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22472230 |
| 112 | Morphine addiction_Homo sapiens_hsa05032 | 0.20098922 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.19987577 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19688765 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.18639177 |
| 116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17609815 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.17489661 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.16997760 |
| 119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16871948 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.15187396 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15021347 |
| 122 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.13505523 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.12408166 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.12318382 |
| 125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11567788 |
| 126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.10914471 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.10790660 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07804727 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.07784583 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.06162047 |

